MENU
SLNO
Stock ticker:
PRICE
CHANGE
CAPITALIZATION

Soleno Therapeutics (SLNO) Ownership - Who owns Soleno Therapeutics?

Profile

Industry
Medical Specialties
Address
203 Redwood Shores Parkway
Phone
+1 650 213-8444
Employees
42
Web
https://www.soleno.life

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.96B
P/E Ratio
N/A
Total Cash
266.12M
Projected Growth
N/A
Total Debt
296K
Revenue
N/A
Risk (Beta)
-3.17
Dividend Yield
N/A
Total Cash/Share
6.85
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

SLNO
Capitalization
1.96B
P/E Ratio
N/A
Risk (Beta)
-3.17
Dividend Yield
N/A
Total Cash
266M
Total Cash/Share
6.85
Total Debt
296K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
281M
P/B Ratio
6.99
Cash Flow
N/A
Earnings
-1.83
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
38K
Current Ratio
29.24
Current Revenue Per Employee
50.00
Dividends Per Share - Security
N/A
EBITDA
-66.53M
Float
N/A
Float - Current
N/A
Gross Income Margin
-4100.00
Revenue To Assets
-39.04
Shares Held By Institutions
2.28B
Shares Outstanding - Current
38.9M
Total Liabilities
23.4M
Total Volume MTD
N/A
Value
-1
Gain YTD
33.814
View a ticker or compare two or three
SLNO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of medical diagnostics and therapeutics based on its proprietary technology for precision metering of gas flow

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
203 Redwood Shores Parkway
Phone
+1 650 213-8444
Employees
42
Web
https://www.soleno.life